Reference number : 236-2016-2017-Q1-00273, amendment number : , agreement type : G, recipient legal name : Bernatsky, Sasha R, recipient country : CA, recipient province : QC, recipient city : Montreal, recipient postal code : H3G 1A4, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 100000.0, agreement start date : 2016-06-01, agreement end date : 2017-05-31, description english : Intravitreal bevacizumab for retinal conditions: real-world safety assessment, description french : Intravitreal bevacizumab for retinal conditions: real-world safety assessment, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2016-17 to 2017-18), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2016-17 à 2017-18), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada